紫金科的内植物:它们的生物活性代谢产品的分布和生物活性
Nor Hazwani Mohd Hasali1, Muhammad Shahbaz2, Jaya Seelan Sathiya Seelan3
1Faculty of Earth Science, Universiti Malaysia Kelantan (UMK) Jeli Campus, 17600, Jeli, Kelantan, Malaysia.
Archives of microbiology
|May 13, 2025
概括
来自紫杉科植物的内细胞产生具有医疗和农业益处的生物活性化合物. 研究强调了它们的抗真菌,抗癌和抗菌潜力,其中包括Streptomyces spp. 作为主要生产商.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 农业科学 农业科学
背景情况:
- 与生根树家族相关的内植物拥有具有重要的医疗和农业应用的生物活性化合物.
- 这些共生微生物的二次代谢产物表现出多种生物活性,包括抗真菌,抗癌,抗糖尿病,抗炎和抗菌性质.
研究的目的:
- 审查由辛吉贝拉属植物内植物产生的生物活性代谢产物.
- 探索它们对各种病原体的潜在生物活性,以及它们在植物生长中的植物激素生产中的作用.
- 进行对研究趋势,合作的文献计量分析,并确定该领域的知识差距.
主要方法:
- 文献综述,重点关注来自Zingiberaceae内植物的生物活性代谢物及其生物活动.
- 从Scopus数据库中对75篇出版物的图书统计分析,以确定研究趋势,主要贡献者和协作网络.
- 识别常见报告的内植物及其产生的生物活性物质.
主要成果:
- 印度是该领域研究的主要贡献者,占总出版物的38.7%.
- 杆菌种类 (Streptomyces spp.) 是一种杆菌. 经常被认为是强大的内植物,产生具有显着抗菌活性的 වැනි林和雷萨塞托芬等化合物.
- 图书统计分析揭示了研究缺口和新兴趋势,突出了未来研究的领域.
结论:
- 紫金科植物相关的内植物是生物活性化合物的宝贵来源,具有潜在的治疗和农业应用.
- 需要进一步的研究来探索这些内植物及其代谢物的全部潜力,解决现有的知识差距.
- 鉴定的趋势和协作为未来在这个有前途的领域的研发提供了路线图.
更多相关视频
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
9.7K
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
6.2K
相关概念视频
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
162
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
162
01:23Factors Influencing Bioavailability: First-Pass Elimination
5.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
5.9K
01:13Bioavailability: Overview
2.6K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.6K